MENU

FATE Fate Therapeutics Forecast, Technical & Fundamental Analysis

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology
FATE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
FATE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

FATE is expected to report earnings to rise 3.85% to -27 cents per share on August 05

Fate Therapeutics FATE Stock Earnings Reports
Q2'26
Est.
$-0.27
Q1'26
Beat
by $0.02
Q4'25
Est.
$-0.27
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.05
The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -28 cents. With 5.69M shares outstanding, the current market capitalization sits at 249.44M.
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
161
Web
https://www.fatetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSEMX21.310.81
+3.95%
Touchstone Sands Cptl Emerg Mkts Gr Y
LICFX21.820.47
+2.20%
Lord Abbett International Equity F
FTYCX54.610.25
+0.46%
FullerThaler Behavioral Sm-Cp Eq C
NWXUX12.230.05
+0.41%
Nationwide International Sm Cp R6
GDIIX25.01-0.21
-0.83%
Genter Dividend Income

FATE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with NKTX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
+6.63%
NKTX - FATE
51%
Loosely correlated
+8.33%
EDIT - FATE
46%
Loosely correlated
+5.49%
VCYT - FATE
44%
Loosely correlated
+4.56%
CABA - FATE
42%
Loosely correlated
N/A
PTN - FATE
41%
Loosely correlated
-4.33%
More
Fate Therapeutics (FATE) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com